Excessive activation of HCK is associated with various leukemia, such as CML, multiple myeloma, and acute lymphoblastic leukemia, as well as solid malignancies including colorectal, breast, and gastric cancer [11–13]. This evidence concerns the gene HCK and chronic myelogenous leukemia, BCR-ABL1 positive.